1-methyl-4-phenylpyridinium has been researched along with Adipocere in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Andersen, JK; Ghosh, A; Hernandez-Quijada, K; Kim, YH; Ko, HS; Ma, SX; Seo, BA; Verma, DK | 1 |
Chung, KC; Darnell, RB; Hwang, IY; Hwang, JY; Kang, HW; Kim, K; Kim, S; Lee, J; Oh, CK; Oh, YJ; Park, HC; Park, WY; Shin, JH; Um, HD; Um, JW | 1 |
Conn, KJ; Eisenhauer, PB; Fine, RE; Gao, W; Lan, MS; McKee, A; Ullman, MD; Wells, JM | 1 |
3 other study(ies) available for 1-methyl-4-phenylpyridinium and Adipocere
Article | Year |
---|---|
Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson's Disease Models.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Animals; Astrocytes; Biomarkers; Brain; Cell Line; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Dopaminergic Neurons; Female; Glial Fibrillary Acidic Protein; HMGB1 Protein; Homeodomain Proteins; Humans; Lamin Type B; Male; Mice, Inbred C57BL; Microglia; Parkinson Disease; Postmortem Changes; Rats | 2021 |
Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Calpain; Cell Death; Cell Line; Disease Models, Animal; Dopaminergic Neurons; Down-Regulation; Mesencephalon; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotection; Parkinson Disease; Postmortem Changes; Proteolysis; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase; Ubiquitin | 2016 |
Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology.
Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Aged; Aged, 80 and over; Analysis of Variance; Animals; Blotting, Northern; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Dopamine; Female; Gene Expression Regulation; Humans; Immunohistochemistry; Lewy Bodies; Male; Middle Aged; Neuroblastoma; Nuclear Proteins; Parkinsonian Disorders; Postmortem Changes; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tretinoin | 2004 |